ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671190 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671190; 2) Community: the network communities that were significantly associated with the response to NSC 671190; 3) Molecule: the relationships between components within communities and NSC 671190; 4) MDR: the compounds that were significantly associated with the NSC 671190.

NSC Compound Enrichment Correlation
NSC 646122 Null 0.00626555836518783 0.42485638
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.00626555836518794 0.48273228
NSC 684909 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 0.00626555836518794 0.37143993
NSC 72942 DL-Noformicin 0.00626555836518794 -0.39818949
NSC 736099 Null 0.00626555836518794 0.3023438
NSC 748262 Null 0.00626555836518794 0.36936644
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.00627320055153809 0.13058814
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00627320055153809 0.33680954
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00627320055153809 0.52432448
NSC 42972 Null 0.00627320055153809 0.51426678
Total:72  Current:14    [First] [Prev] [Next] [Last]